---
figid: PMC4826776__DialoguesClinNeurosci-18-99-g003
figlink: /pmc/articles/PMC4826776/figure/DialoguesClinNeurosci-18-99-g003/
number: F3
caption: 'In Parkinson disease, dopamine arising from the substantia nigra pars compacta
  is thought to activate D1-expressing striatal medium spiny neurons of the direct
  pathway (red lines) and to inhibit D2-expressing striatal neurons of the indirect
  pathway (blue lines). The output nuclei globus pallidus interna and substantia nigra
  pars reticulata project to the thalamus, which in turn sends efferents that complete
  the cortico-basal ganglia-thalamo-cortical loop. In Parkinson disease, degeneration
  of nigral neurons reduces dopamine-receptor stimulation in striatal medium spiny
  neurons. The imbalance between direct and indirect pathways results in abnormal
  activation of output nuclei and overinhibition of thalamic neurons projecting to
  the cortex. DA, dopamine; GPe, globus pallidus externa; GPi, globus pallidus interna;
  SNc, substantia nigra pars compacta; SNr, substantia nigra pars reticulata; STN,
  subthalamic nucleus. Reproduced from reference 29: Calabresi P, Picconi B, Tozzi
  A, Ghiglieri V, Di Filippo M. Direct and indirect pathways of basal ganglia: a critical
  reappraisal. Nat Neurosci. 2014;17(8):1022-1030. Copyright © Nature Publishing Group,
  2014.'
pmcid: PMC4826776
papertitle: Optogenetic approaches to evaluate striatal function in animal models
  of Parkinson disease.
reftext: Krystal L. Parker, et al. Dialogues Clin Neurosci. 2016 Mar;18(1):99-107.
pmc_ranked_result_index: '107080'
pathway_score: 0.8449786
filename: DialoguesClinNeurosci-18-99-g003.jpg
figtitle: Optogenetic approaches to evaluate striatal function in animal models of
  Parkinson disease
year: '2016'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4826776__DialoguesClinNeurosci-18-99-g003.html
  '@type': Dataset
  description: 'In Parkinson disease, dopamine arising from the substantia nigra pars
    compacta is thought to activate D1-expressing striatal medium spiny neurons of
    the direct pathway (red lines) and to inhibit D2-expressing striatal neurons of
    the indirect pathway (blue lines). The output nuclei globus pallidus interna and
    substantia nigra pars reticulata project to the thalamus, which in turn sends
    efferents that complete the cortico-basal ganglia-thalamo-cortical loop. In Parkinson
    disease, degeneration of nigral neurons reduces dopamine-receptor stimulation
    in striatal medium spiny neurons. The imbalance between direct and indirect pathways
    results in abnormal activation of output nuclei and overinhibition of thalamic
    neurons projecting to the cortex. DA, dopamine; GPe, globus pallidus externa;
    GPi, globus pallidus interna; SNc, substantia nigra pars compacta; SNr, substantia
    nigra pars reticulata; STN, subthalamic nucleus. Reproduced from reference 29:
    Calabresi P, Picconi B, Tozzi A, Ghiglieri V, Di Filippo M. Direct and indirect
    pathways of basal ganglia: a critical reappraisal. Nat Neurosci. 2014;17(8):1022-1030.
    Copyright © Nature Publishing Group, 2014.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EEF1A2
  - GYPE
  - GPI
genes:
- word: STN
  symbol: STN
  source: hgnc_prev_symbol
  hgnc_symbol: EEF1A2
  entrez: '1917'
- word: GPe
  symbol: GPE
  source: hgnc_alias_symbol
  hgnc_symbol: GYPE
  entrez: '2996'
- word: GPi
  symbol: GPI
  source: hgnc_symbol
  hgnc_symbol: GPI
  entrez: '2821'
chemicals: []
diseases: []
figid_alias: PMC4826776__F3
redirect_from: /figures/PMC4826776__F3
figtype: Figure
---
